Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
Midas Letter RAW is the irreverent, intelligent show about investing for the little guy. Ed Milewski, former stock broker and reformed accountant brings his cynical and off-beat chart observations int... more
FAQs about Midas Letter:How many episodes does Midas Letter have?The podcast currently has 1,015 episodes available.
March 10, 2022“We’ve Found a Treasure Chest of Metals” (Gold, Magnesium, Nickel) | Green River Gold $CCR $CCRRFGreen River Gold Corp (CNSX:CCR, OTCMKTS:CCRRF) has always seen a near-term cash flow potential for hard rock gold discoveries in its projects located in the rich mining history of the Cariboo District. The company has 26 square kilometres of gold properties with great regional […]...more13minPlay
March 08, 2022Only North American Graphite Producer Supplying EV & Battery Markets | Northern Graphite $NGC $NGPHFNorthern Graphite Corp (CVE:NGC, OTCMKTS:NGPHF) is a graphite exploration and producing company that will supply the forecasted growth in electric vehicle (EV) and battery demand. In December, the company announced the acquisition of two graphite-producing projects from Imerys SA (EPA:NK, OTCMKTS:IMYSF) – one […]...more10minPlay
March 04, 2022Russia/Ukraine Crisis Effect on Stocks, Oil & Markets | Midas Letter RAW ft $NGC $CWRKStocks are slumping this Friday with continued worries over Russia’s invasion of Ukraine. The Russia/Ukraine crisis offsetting any chance of good news stemming from a strong U.S. payrolls report. Hiring across the United States grew last month as the economy recovers from […]...more1h 2minPlay
March 03, 2022FinTech Company Building B2B NFT Offerings | CurrencyWorks $CWRKCurrencyWorks Inc (CNSX:CWRK, OTCMKTS:CWRK) is a FinTech company that builds turnkey blockchain solutions to expand exiting corporations’ markets and create strategic differentiators for their businesses. B2B solutions could include digital currencies, payment rails, NFTs, STOs, and any combination of digital assets inside an ecosystem. […]...more12minPlay
February 24, 20223 Reasons to Watch This Psychedelics Stock | Cybin $CYBNCybin Inc (NEO:CYBN, NYSEAMERICAN:CYBN) is taking classical psychedelics like MDMA, psilocybin, and DMT and turning them into therapeutics for mental health disorders like depression and addiction. The original psychedelic compounds can be very aggressive and provide unwanted side effects. Cybin aims to […]...more11minPlay
February 23, 2022Voxtur Analytics $VXTR $VXTRF 2022 Growth CatalystsVoxtur Analytics Corp (CVE:VXTR, OTCMKTS:VXTRF) recently updated its corporate presentation to highlight an increase in full-year revenues of 58% in 2021. As seen from the slide below, company revenues have been growing every year. But, 2021 was by far Voxtur’s best year […]...more21minPlay
February 18, 2022The 2022 PropTech Video You Have Been Waiting For | Midas Letter Daily ft $VXTRPropTech is one of the fastest-growing sectors in the world today. Real estate technology is reshaping the largest asset class in the world. Real estate data has historically been incomplete, contained errors, and lacked transparency. This inefficiency makes the $9 Trillion commercial […]...more28minPlay
February 18, 2022A Bull Market Begets a Bear Market | Midas Letter Daily ft $CYBNThere’s some blood in the streets as all major indices are down. The S&P 500 fell 2.1% with the Nasdaq sinking 2.9%. The Russian/Ukraine geopolitical instability indicators still concern investors coupled with surging inflation and how the Federal Reserve plans to fight it. […]...more22minPlay
February 17, 2022European Battery Making Capacity Outweighs Supply | United Lithium $ULTH $ULTHFLithium has been the hottest commodity since sliced bread this year. The surge for the metal comes from it being one of the key components used in rechargeable batteries powering electric vehicles (EV). With the massive adoption of EVs over the last […]...more10minPlay
February 16, 2022Groundbreaking Drug Treating Nervous System Injuries | NervGen $NGEN $NGENFThere are no approved drugs that treat nervous system and spinal injuries past stabilizing the patient. There is nothing proved in the clinic to treat injured patients actually recover. NervGen Pharma Corp (CVE:NGEN, OTCMKTS:NGENF) is looking to change that by developing a new class of […]...more11minPlay
FAQs about Midas Letter:How many episodes does Midas Letter have?The podcast currently has 1,015 episodes available.